Study Information
| Title: | Cediranib and Olaparib in Combination for Recurrent Ovarian or Triple-Negative Breast Cancer  |
| Status: | Recruiting participants |
| Conditions: | Ovarian Cancer; Primary Peritoneal Cancer; Fallopian Tube Cancer |
| Interventions: | Drug: cediranib; Drug: olaparib |
| Institutions: | Beth Israel Deaconess Medical Center, Dana-Farber Cancer Institute, Massachusetts General Hospital |
| Health Topics: | Fallopian Tube Cancer, Ovarian Cancer |
Contact Information
Beth Israel Deaconess Medical Center
Boston, MA 02115
Dana-Farber Cancer Institute
Boston, MA 02115
Christin Whalen, RN
christin_whalen@dfci.harvard.edu
Massachusetts General Hospital
Boston, MA 02114